Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × folfirinox × Clear all

NCT03812783 2019-01-23

HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular